Bonnie Kiesling | Head of US Marketing
ITF Therapeutics
Bonnie Kiesling is an accomplished commercial leader with more than 20 years of experience driving revenue growth and profitability through innovation in the pharmaceutical and biotechnology industries. She is recognized for building high-performing teams, leveraging customer insights to shape business strategy, and leading successful product launches supported by best-in-class marketing strategies. Prior to joining ITF Therapeutics, Bonnie held roles of increasing responsibility at Sage Therapeutics, Biogen, and Pfizer, contributing to brand strategy and commercialization efforts across multiple therapeutic areas including depression, multiple sclerosis, and fertility.
As Head of Marketing at ITF Therapeutics, Bonnie leads product marketing across the rare disease business, translating deep customer and market insights into targeted promotional strategies for patients and healthcare providers.
Appearances:
Day 1 - World Orphan Drug Congress USA 2026 @ 11:30
Empowering Patients as Partners: Driving Orphan Drug Market Success Through Advocacy and Engagement
In rare disease, patient-centricity is often described as essential, yet it isn’t always prioritized through development and launch decisions. This session will explore what true partnership actually requires and how industry can better understand and reflect the lived experience in meaningful ways. The discussion will feature a candid caregiver interview to highlight where gaps remain and what authentic engagement looks like in practice.
Objectives
- Clarify what meaningful patient partnership truly entails
- Examine gaps between industry assumptions and lived experience
- Identify practical ways to ensure patient perspectives influence key decisions
- Highlight the connection between authentic engagement and long-term success
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events